| Literature DB >> 30079487 |
Tara R deBoer1, Nicole J Tarlton2, Reina Yamaji2, Sheila Adams-Sapper2, Tiffany Z Wu2, Santanu Maity1, Giri K Vesgesna1, Corinne M Sadlowski1, Peter DePaola1, Lee W Riley2, Niren Murthy1.
Abstract
Biochemical assays that can identify β-lactamase activity directly from patient samples have the potential to significantly improve the treatment of bacterial infections. However, current β-lactamase probes do not have the sensitivity needed to measure β-lactam resistance directly from patient samples. Here, we report the development of an instrument-free signal amplification technology, DETECT, that connects the activity of two enzymes in series to effectively amplify the activity of β-lactamase 40 000-fold, compared to the standard β-lactamase probe nitrocefin.Entities:
Keywords: amplification; antimicrobial resistance; beta-lactamases; diagnostics; point-of-care diagnosis
Mesh:
Substances:
Year: 2018 PMID: 30079487 PMCID: PMC6494105 DOI: 10.1002/cbic.201800443
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164